The Missing Millions: A Threat to the Elimination of Leprosy by Smith, W.C. (William Cairns) et al.
VIEWPOINTS
The Missing Millions: A Threat to the
Elimination of Leprosy
William Cairns Smith1*, Wim van Brakel2, TomGillis3, Paul Saunderson4,
Jan Hendrik Richardus5
1 School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom, 2 Netherlands
Leprosy Relief, Amsterdam, Netherlands, 3 effect: hope, The Leprosy Mission, Markham, Ontario, Canada,
4 American Leprosy Missions, Greenville, South Carolina, United States of America, 5 Erasmus MC,
University Medical Center, Rotterdam, Netherlands
* w.c.s.smith@abdn.ac.uk
Introduction
Leprosy is a slow, chronic disease with a long incubation period caused byMycobacterium
leprae. The clinical presentation varies across a wide spectrum from tuberculoid to leproma-
tous leprosy. The condition is characterized by skin lesions and damage to peripheral nerves
leading to physical disability and social problems. The past 50–60 years have witnessed remark-
able progress in the fight against leprosy. The introduction of dapsone therapy in the late 1940s
was the first effective treatment for leprosy, and this was followed by the move to short course
multidrug therapy (MDT) in 1981. The World Health Assembly Resolution in 1991 [1] to
“eliminate leprosy as a public health problem” by the year 2000 galvanised extraordinary inter-
national support resulting in the fall in the point prevalence of patients registered for treatment
of leprosy by over 90% to less than 1 in 10,000 at the global level. The effort was led by the
World Health Organization (WHO) and supported by national governments and their health
service staff, the Nippon Foundation, Novartis, the International Federation of Anti-Leprosy
Organizations (ILEP), local non-governmental organizations (NGOs), and by people affected
by leprosy. Since 2000, the focus has moved from prevalence of leprosy to incidence as mea-
sured by reported new case detection to sustain the achievements and to reduce the burden of
disease, particularly on reduction and prevention of disability associated with leprosy and reha-
bilitation of those facing the long-term consequences of the disease [2].
Understanding Transmission
Despite this remarkable progress, understanding of the pathogenesis of leprosy has remained
unclear. Basic knowledge of the transmission ofM. leprae, portals of exit and entry, the role of
the environment and animal reservoirs, the development of immune responses following infec-
tion, and the pathogenesis ofM. leprae infection to the disease of leprosy are all limited. A re-
cent expert group, hosted by effect: hope (The Leprosy Mission Canada) and the National
School of Tropical Medicine at Baylor College of Medicine in Houston, Texas, United States,
reviewed the evidence and recent research on transmission and how to block it. Novel methods
in strain typingM. leprae and recent findings in both host genetics and immune responses
open the potential for new solutions. However, the very long incubation period, the very low
incidence rates in those exposed, and the insidious clinical presentation create real challenges
to developing strategies to interrupt transmission [3].
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Global Trends in Leprosy
Global data on the trends in new case detection in leprosy are collated and published annually
by WHO [4]. There are concerns about the quality and completeness of these data [5,6]. These
data describe new case trends from detection through the completion of MDT at national, re-
gional, and global levels. Fig 1 plots the number of new leprosy cases by year. The red continu-
ous line represents the observed annual new case detection rate between 1985 and 2012, with
extrapolation to 2020 based on the trend after 2005 (red dotted line). The blue continuous line
is the predicted new case detection rate based on modeling with the SIMLEP model, applying
an intermediate scenario in the presence of an infant BCG vaccination programme [7]. These
trends in the last decade show a very striking feature (Fig 1, red line): a dramatic and sudden
decline in new case detection of over 60% over a short period of time (2001–2005). Under-
standing the possible explanations for this dramatic fall is very important. One explanation is
that this represents a true fall in the incidence of leprosy following reduction in transmission of
M. leprae infection. Disease modeling work [7] has suggested that the long-term underlying
trend in leprosy incidence in a good scenario including infant BCG immunization is a slow,
gradual decline of around 4.4% per year. A large, sudden fall in transmission seems biologically
implausible given the long and variable incubation period in leprosy and the evidence of con-
tinuing, significant rates of new cases in children [4]. A second explanation is that there was
substantial overdiagnosis of leprosy prior to 2001, which has inflated the previous levels of new
case detection. This may be a factor to explain the peak of new case detection between 1996
and 2001, a period of intensified case detection activities [8], such as Leprosy Elimination Cam-
paigns (LEC) and Special Action Projects for the Elimination of Leprosy (SAPEL). However,
the new case detection trends between 1985 and 1996 are remarkably stable and sustained
overdiagnosis seems unlikely over this period. The third, and most probable, explanation is
that the dramatic fall in new case detection is a result of a decline in leprosy activities following
the declaration of elimination as a public health problem globally, and in individual countries.
This decline includes reduced intensity and coverage of case detection activities, community
awareness, and training in the diagnosis and treatment of leprosy often associated with the
move from vertical leprosy control activities to integrated approaches. The recent rise in dis-
ability in new cases detected and the increasing delay in diagnosis reported by many countries
Fig 1. Number of new leprosy cases by year. The red continuous line represents the observed annual new case detection rate between 1985 and 2012,
with extrapolation to 2020 based on the trend after 2005 (red dotted line). The blue continuous line is the predicted new case detection rate based on
modeling with the SIMLEPmodel, applying an intermediate scenario in the presence of an infant BCG vaccination programme [7].
doi:10.1371/journal.pntd.0003658.g001
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supports this explanation [4]. WHO, along with the Nippon Foundation, called an Internation-
al Leprosy Summit in 2013 to address what they called “stagnation” in the leprosy control. This
resulted in the Bangkok Declaration [9], signed by the health ministers of the major leprosy en-
demic countries, calling for renewed political commitment to leprosy control.
The Implications of the Decline in New Case Detection for the
Elimination of Leprosy
Fig 1 shows how the model prediction of the long-term trend in new leprosy case detection
based on the observed figures before 2000 compares with the observed new case detection. The
resulting difference between the expected and observed numbers of new cases of leprosy be-
tween 2000 and 2012 is approximately over 2.6 million. This number will increase to over 4
million by 2020. This analysis implies that there may be a large accumulation of people with
leprosy in the community who remain undiagnosed and untreated. This assertion is supported
by evidence from recent sample surveys in endemic areas detecting many as yet untreated cases
in Bangladesh [10] and in India [11]. This large number of undetected cases represents a major
threat to leprosy control and contributes to the increased burden of infection in the community
and an increased pressure on transmission. This has major consequences for the road map for
NTDs in the London Declaration [12–14], which targets “interruption of transmission” and
“global elimination” of leprosy by 2020.
Response to This Threat to Leprosy Elimination
It is vital that all involved and concerned with leprosy control appreciate this situation and rec-
ognise that the London Declaration targets of “global elimination” of leprosy and “interruption
of transmission” by 2020 are likely to be unobtainable and that revised targets are needed.
Major commitments and resources need to be made available without delay. While local elimi-
nation (based on new cases detected in a defined locality) of leprosy through targeted leprosy
control activities as recommended byWHO is necessary in the short-term, the complete inter-
ruption of transmission at a global level will require new tools based on game-changing discov-
eries. A significant investment in complementary research efforts, designed to better understand
the basic elements of transmission, is necessary for achieving “interruption of transmission.”
The development of collaboration with other NTD programmes represents a real opportu-
nity to improve the coverage, quality, and cost-effectiveness of leprosy control with numerous
cross-cutting opportunities in drug delivery, surveillance, training, disability prevention, and
morbidity management. The commitment called for by health ministers in the Bangkok Decla-
ration is also essential at all levels, internationally, nationally, and locally by national govern-
ments and by all agencies that support national programmes, including Governmental and
non-governmental agencies, industry, and people affected by leprosy. The global introduction
of post-exposure prophylaxis [15–17] is a real opportunity to re-energise leprosy control activi-
ties through increased community awareness, capacity building, and active management of
contacts. The research opportunity recently launched by the Leprosy Research Initiative leads
the way to develop further innovations for leprosy control, but much more support is needed
for basic, as well as operational, research to develop strategies to interrupt transmission. For ex-
ample, recent findings have revealed new insights into zoonotic relationships, genetic markers
for host susceptibility and resistance, as well as environmental factors that continue to test our
long-held notions of the ecology ofM. leprae and leprosy. Understanding these relationships
may provide the knowledge to move from management practices to strategies designed to
stop transmission.
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The WHO priority to promote early detection and to monitor this through measuring dis-
ability in new case detection is a vital component to evaluate enhanced initiatives designed to
reduce transmission. However, addressing the gap between the incidence and case detection of
leprosy requires improved strategies for case detection, new tools for early diagnosis, and
major efforts to improve community awareness and capacity of health staff to diagnose and
manage leprosy and its complications.
The challenge is to tackle the research gaps through novel collaborations, to improve opera-
tional collaborations with multiple players in all NTDs, and to incorporate new approaches in
community engagement that would enhance public health at the community level. The leprosy
world, including WHO, national governments, NGOs, the research community, and industry,
together with people affected by leprosy, must respond to this situation that, if left unaddressed,
could see all the past achievements in leprosy control reversed.
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